Literature DB >> 10073274

Coagulase-negative staphylococci: role as pathogens.

J Huebner1, D A Goldmann.   

Abstract

Coagulase-negative staphylococci have long been regarded as apathogenic but their important role as pathogens and their increasing incidence have been recognized and studied in recent years. Although specific virulence factors are not as clearly established as they are in Staphylococcus aureus, it seems clear that factors such as bacterial polysaccharide components are involved in attachment and/or persistence of bacteria on foreign materials. Coagulase-negative staphylococci are by far the most common cause of bacteremia related to indwelling devices. Most of these infections are hospital-acquired, and studies over the past several years suggest that they are often caused by strains that are transmitted among hospitalized patients. Other important infections due to coagulase-negative staphylococci include central nervous system shunt infections, native or prosthetic valve endocarditis, urinary tract infections, and endophthalmitis. Intravenous treatment of systemic infections is usually required because coagulase-negative staphylococci have become increasingly resistant to multiple antibiotics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073274     DOI: 10.1146/annurev.med.50.1.223

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  107 in total

1.  Single-base-pair discrimination of terminal mismatches by using oligonucleotide microarrays and neural network analyses.

Authors:  Hidetoshi Urakawa; Peter A Noble; Said El Fantroussi; John J Kelly; David A Stahl
Journal:  Appl Environ Microbiol       Date:  2002-01       Impact factor: 4.792

2.  Rapid and accurate identification of coagulase-negative staphylococci by real-time PCR.

Authors:  K J Edwards; M E Kaufmann; N A Saunders
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

3.  Purification and characterization of recombinant Staphylococcus haemolyticus DNA gyrase and topoisomerase IV expressed in Escherichia coli.

Authors:  Joel C Bronstein; Stacey L Olson; Kristin LeVier; Mark Tomilo; Peter C Weber
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

4.  Comparative study using phenotypic, genotypic, and proteomics methods for identification of coagulase-negative staphylococci.

Authors:  Anne J M Loonen; Arjan R Jansz; Jeandery N B Bergland; Marion Valkenburg; Petra F G Wolffs; Adriaan J C van den Brule
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 5.  Strategies to decrease the risk of ventricular catheter infections: a review of the evidence.

Authors:  Maya A Babu; Robin Patel; W Richard Marsh; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

6.  First report of Staphylococcal clinical isolates in Mexico with linezolid resistance caused by cfr: evidence of in vivo cfr mobilization.

Authors:  Rodrigo E Mendes; Lalitagauri Deshpande; Eduardo Rodriguez-Noriega; James E Ross; Ronald N Jones; Rayo Morfin-Otero
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

Review 7.  Peptide signaling in the staphylococci.

Authors:  Matthew Thoendel; Jeffrey S Kavanaugh; Caralyn E Flack; Alexander R Horswill
Journal:  Chem Rev       Date:  2010-12-21       Impact factor: 60.622

8.  Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence.

Authors:  Maren Rautenberg; Hwang-Soo Joo; Michael Otto; Andreas Peschel
Journal:  FASEB J       Date:  2010-12-23       Impact factor: 5.191

9.  Detection of benzalkonium chloride resistance in community environmental isolates of staphylococci.

Authors:  Gui-Xin He; Michael Landry; Huizhong Chen; Conner Thorpe; Dennis Walsh; Manuel F Varela; Hongmiao Pan
Journal:  J Med Microbiol       Date:  2014-02-28       Impact factor: 2.472

10.  Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin.

Authors:  R E Polonio; L A Mermel; G E Paquette; J F Sperry
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.